IMMUNEPRO Trademark

Trademark Overview

On Wednesday, October 17, 2018, a trademark application was filed for IMMUNEPRO with the United States Patent and Trademark Office. The USPTO has given the IMMUNEPRO trademark a serial number of 88158792. The federal status of this trademark filing is REGISTERED as of Tuesday, September 22, 2020. This trademark is owned by OneLogic, Inc.. The IMMUNEPRO trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Consulting services in the field of hormone replacement therapy; Medical evaluation of immune system issues and deficiencies; Medical services; Providing medical advice in the field of immunology
immunepro

General Information

Serial Number88158792
Word MarkIMMUNEPRO
Filing DateWednesday, October 17, 2018
Status700 - REGISTERED
Status DateTuesday, September 22, 2020
Registration Number6160297
Registration DateTuesday, September 22, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkIMMUNE PRO
Goods and ServicesConsulting services in the field of hormone replacement therapy; Medical evaluation of immune system issues and deficiencies; Medical services; Providing medical advice in the field of immunology

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 29, 2018
Primary Code044
First Use Anywhere DateWednesday, January 1, 2020
First Use In Commerce DateWednesday, January 1, 2020

Trademark Owner History

Party NameOneLogic, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoca Raton, FL 33431
Party NameOneLogic, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoca Raton, FL 33431

Trademark Events

Event DateEvent Description
Saturday, October 20, 2018NEW APPLICATION ENTERED
Monday, October 29, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 23, 2019ASSIGNED TO EXAMINER
Thursday, January 31, 2019NON-FINAL ACTION WRITTEN
Thursday, January 31, 2019NON-FINAL ACTION E-MAILED
Thursday, January 31, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 5, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 5, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 30, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 30, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 30, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 5, 2019NON-FINAL ACTION WRITTEN
Monday, August 5, 2019NON-FINAL ACTION E-MAILED
Monday, August 5, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 27, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 27, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 27, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 13, 2020FINAL REFUSAL WRITTEN
Thursday, February 13, 2020FINAL REFUSAL E-MAILED
Thursday, February 13, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, July 24, 2020TEAS AMENDMENT OF USE RECEIVED
Friday, July 24, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, July 24, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 24, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, July 25, 2020USE AMENDMENT FILED
Saturday, July 25, 2020AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, July 28, 2020USE AMENDMENT ACCEPTED
Tuesday, July 28, 2020APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Wednesday, July 29, 2020NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Monday, August 3, 2020ASSIGNED TO LIE
Sunday, August 9, 2020ASSIGNED TO LIE
Monday, August 17, 2020LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 22, 2020REGISTERED-SUPPLEMENTAL REGISTER
Monday, September 22, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

immunepro medical field services deficiencies issues advice immunology system providing evaluation